“I like to call it the walking pill because it’s made my walking so much better.” - Bambi

How to Take AMPYRA

Take AMPYRA® (dalfampridine) exactly as your doctor tells you to take it. Do not change your dose of AMPYRA. Take one tablet of AMPYRA 2 times each day about 12 hours apart. Do not take more than 2 tablets of AMPYRA in a 24-hour period.

Take AMPYRA tablets whole. Do not break, crush, chew or dissolve AMPYRA tablets before swallowing. If you cannot swallow AMPYRA tablets whole, tell your doctor. AMPYRA is released slowly over time. If the tablet is broken, the medicine may be released too fast. This can raise your chance of having a seizure.

AMPYRA can be taken with or without food.

You can take AMPYRA regardless of what type of multiple sclerosis (MS) you have

AMPYRA has been shown to improve walking across the four major types of MS. AMPYRA does not work for everyone. Individual results may vary.

You can take AMPYRA with your current MS medication

You can take AMPYRA even if you are taking other medications for MS, including your disease-modifying therapy. AMPYRA is not meant to replace your current MS medication.

Always tell your doctor about all of the other medications you are taking.

NEXT: Walking Progress Tracker
Print A A
Questions?

1-888-881-1918

First Step Program First Step
Program

Need help taking the first step? Find out if you are eligible for
a FREE trial of AMPYRA.
Learn More

Walk Talk Walk Talk
Email Program

Join for:
  • AMPYRA information
  • Help talking to your doctor
  • MS-related walking education
Sign up now

AMPYRA® (dalfampridine) is indicated as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.

IMPORTANT NEW SAFETY INFORMATION

Do not take AMPYRA if you are allergic to dalfampridine (4-aminopyridine), the active ingredient in AMPYRA.

IMPORTANT SAFETY INFORMATION

Do not take AMPYRA if you have ever had a seizure, or have certain types of kidney problems, or are allergic to dalfampridine (4-aminopyridine), the active ingredient in AMPYRA.

Take AMPYRA exactly as prescribed by your doctor.

You could have a seizure even if you never had a seizure before. Your chance of having a seizure is higher if you take too much AMPYRA or if your kidneys have a mild decrease of function, which is common after age 50.

Your doctor may do a blood test to check how well your kidneys are working, if that is not known before you start taking AMPYRA.

AMPYRA may cause serious allergic reactions. Stop taking AMPYRA and call your doctor right away or get emergency medical help if you have shortness of breath or trouble breathing, swelling of your throat or tongue, or hives.

AMPYRA should not be taken with other forms of 4-aminopyridine (4-AP, fampridine), since the active ingredient is the same.

The most common adverse events for AMPYRA in MS patients were urinary tract infection, trouble sleeping, dizziness, headache, nausea, weakness, back pain, and problems with balance.

Before taking AMPYRA tell your doctor if you are pregnant or plan to become pregnant. It is not known if AMPYRA will harm your unborn baby.

Tell your doctor if you are breast-feeding or plan to breast-feed. It is not known if AMPYRA passes into your breast milk. You and your doctor should decide if you will take AMPYRA or breast-feed. You should not do both.

Please see the full Prescribing Information and Patient Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

AMPYRA® is a registered trademark of Acorda Therapeutics®, Inc. | AMPYRA® is marketed by Acorda Therapeutics®, Inc. and manufactured under license from Alkermes Pharma Ireland Limited (APIL), Ireland | AMPYRACONNECT™ is a trademark of Acorda Therapeutics®, Inc. | The stylized path logo is a trademark of Acorda Therapeutics®, Inc. | The stylized Acorda logo is a trademark of Acorda Therapeutics®, Inc. | © 2013 Acorda Therapeutics®, Inc. All rights reserved.

AMP2043